Skip to content

Clinical trials

Observational Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: United Kingdom Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20061
20075
20085
20093
20104
20113
20122
20132
20144
20156
20165
20175
20186
20199
20206
20219
20227
20237
20249
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Unknown status31
Recruiting17
Active, not recruiting8
Terminated4
Not yet recruiting2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Marsden NHS Foundation Trust11
AstraZeneca5
Imperial College London5
University of Aberdeen5
Hoffmann-La Roche4
Institute of Cancer Research, United Kingdom4
The Leeds Teaching Hospitals NHS Trust4
Pfizer3
University College, London3
University of Leeds3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms111
Neoplasms11
Colorectal Neoplasms4
Triple Negative Breast Neoplasms4
Breast Carcinoma In Situ3
Breast Diseases3
Carcinoma, Intraductal, Noninfiltrating3
Colonic Neoplasms3
Prostatic Neoplasms3
Urinary Bladder Neoplasms3

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.